Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1901-1910 of 2869 for cancer

Edit search filters
  1. Testing The Effects Of MK-3475 (Pembrolizumab) With Or Without The Usual Chemotherapy Treatment For Patients 70 Years Of Age And Older With Advanced Non-small Cell Lung Cancer

    Eau Claire, WI, La Crosse, WI

  2. Pembrolizumab Plus Epacadostat Alone Or With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo In Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-02/ECHO-306)

    Rochester, MN

  3. A Study To Compare Whole Brain Radiotherapy And Memantine To Stereotactic Radiosurgery Vs. Stereotactic Radiosurgery Alone To Treat Patients With Cancer That Has Spread To The Brain After Earlier Stereotactic Radiosurgery

    Jacksonville, FL

  4. A Study To Learn About The Medicine Called PF-08634404 Dosed Alone And In Combination With Other Anticancer Therapies In Adults With Locally Advanced Or Metastatic Renal Cell Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Outcomes Of Regional Consensus Treatment Guidelines For Management Of Surgery, Invasive Procedures And Control Of Hemorrhages In Patients With Bleeding Disorders; And Management Of Thrombosis And Thromboprophylaxis In Patients With Thrombophilia

    Rochester, MN

  6. Long-term Outcomes of May-Thurner Syndrome in Pediatric Patients

    Rochester, MN

  7. A Study To Evaluate The Effectiveness And Safety Of CAEL-101 In Patients With Mayo Stage IIIa AL Amyloidosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study To Assess Adverse Events And Change In Disease Activity In Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone Or With Standard Of Care In Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer And No Radiographic Evidence Of Disease

    Jacksonville, FL, Rochester, MN

  9. Validation Of A Flow-micro Immunomagnetic System For Rare Cell Isolation From Peripheral Blood

    Rochester, MN

  10. Study Of Encorafenib + Cetuximab Plus Or Minus Binimetinib Vs. Irinotecan/Cetuximab Or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With A Safety Lead-in Of Encorafenib + Binimetinib + Cetuximab In Patients With BRAF V600E-mutant Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer